{"id":1240,"date":"2026-03-12T14:56:02","date_gmt":"2026-03-12T19:56:02","guid":{"rendered":"https:\/\/elyxaminos.com\/?p=1240"},"modified":"2026-08-25T23:40:12","modified_gmt":"2026-08-26T04:40:12","slug":"semaglutide-vs-tirzepatide-vs-retatrutide-a-comprehensive-comparison-of-glp-1-agonists-in-2026","status":"publish","type":"post","link":"https:\/\/elyxaminos.com\/en\/semaglutide-vs-tirzepatide-vs-retatrutide-comparativa-completa-de-agonistas-glp-1-en-2026\/","title":{"rendered":"Semaglutide vs. Tirzepatide vs. Retatrutide: A Comprehensive Comparison of GLP-1 Agonists in 2026"},"content":{"rendered":"

GLP-1 receptor agonists have revolutionized the field of metabolic optimization. What began as a class of compounds focused on glucose regulation has expanded into a family of molecules with applications ranging from appetite control to improving body composition.<\/p>\n \n

In this comparison, we analyze the three most relevant compounds in this category: Semaglutide, Tirzepatide, and Retatrutide, detailing their mechanisms, differences, and profiles.<\/p>\n \n

What is GLP-1 and Why Does it Matter?<\/h2>\n \n

GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone naturally produced in the intestine after eating. It performs critical functions in metabolic regulation: it stimulates insulin secretion, reduces glucagon production, slows gastric emptying, and activates satiety centers in the brain.<\/p>\n \n

GLP-1 agonists are compounds that mimic or enhance this hormonal action, with variations in their mechanism and target receptors.<\/p>\n \n

The Three Compounds: Overview<\/h2>\n \n
\n\n\n
Feature<\/th>Semaglutide<\/th>Tirzepatide<\/th>Retatrutide<\/th><\/tr><\/thead>\n
Type<\/td>GLP-1 agonist<\/td>Dual GIP\/GLP-1<\/td>GLP-1\/GIP\/Glucagon triple agonist<\/td><\/tr>\n
Receptors<\/td>GLP-1<\/td>GLP-1 + GIP<\/td>GLP-1 + GIP + Glucagon<\/td><\/tr>\n
Frequency<\/td>Weekly<\/td>Weekly<\/td>Weekly<\/td><\/tr>\n
Typical Dose<\/td>0.25\u20131 mg<\/td>2.5-10 mg<\/td>1\u20138 mg (scaled)<\/td><\/tr>\n
Program Duration<\/td>12\u201324 weeks<\/td>12\u201324 weeks<\/td>16\u201336 weeks<\/td><\/tr>\n
Pureza Elyx<\/td>99.935%<\/td>99.654%<\/td>99.692%<\/td><\/tr>\n
Presentation<\/td>5mg vial<\/td>5mg vial<\/td>5mg \/ 10mg vial<\/td><\/tr>\n<\/tbody><\/table><\/div>\n \n \n \n

Semaglutide: The Pioneer<\/h2>\n \n

Semaglutide was the compound that brought the GLP-1 agonist class to prominence. As a selective GLP-1 receptor agonist, it acts on a single hormonal pathway but with high potency and specificity.<\/p>\n \n

Mechanism of action:<\/strong><\/p>\n

It binds to the GLP-1 receptor in multiple tissues. In the pancreas, it stimulates glucose-dependent insulin secretion. In the brain, it activates satiety centers in the hypothalamus, reducing appetite. It also slows gastric emptying, prolonging the feeling of fullness.<\/p>\n \n

Profile:<\/strong><\/p>\n